While NDRG4 downregulation is functionally associated with enhanced lymph node affinity and cell mobility in two non-metastatic and poor invasive breast cancer cell lines, NDRG4 DNA methylation is predictive for the development of metastatic disease. This evidence concerns the gene NDRG4 and metastatic neoplasm.